1. Fatalities following confusion over amphotericin B formulations

   News item 28 July 2018 Pages: 1 - 1

2. Laboratory test interference associated with eltrombopag

   News item 28 July 2018 Pages: 2 - 2

3. MHRA encourages suspected ADR reporting during pregnancy

   News item 28 July 2018 Pages: 3 - 3

4. Montelukast review conducted following neuropsychiatric events

   News item 28 July 2018 Pages: 4 - 4

5. PRAC recommends restricted use of Xofigo for prostate cancer

   News item 28 July 2018 Pages: 5 - 5

6. US FDA: fake warning letters being issued to consumers

   News item 28 July 2018 Pages: 6 - 6

7. Bullous pemphigoid with diabetes medications?

   Clinical study 28 July 2018 Pages: 7 - 7

8. Corticosteroid-related adverse outcomes costly in asthma

   Clinical study 28 July 2018 Pages: 8 - 8

9. HIV prophylaxis: pregnancy outcomes, infant growth

   Clinical study 28 July 2018 Pages: 9 - 9

10. Insulin analogues differ in risk for hypoglycaemia and weight gain

    Clinical study 28 July 2018 Pages: 10 - 10

11. Lipid-lowering drugs linked with depression

    Clinical study 28 July 2018 Pages: 11 - 11

12. Major birth defects with ondansetron

    Clinical study 28 July 2018 Pages: 12 - 12

13. Pulmonary embolism with clozapine

    Clinical study 28 July 2018 Pages: 13 - 13

14. β-lactams

    Case report 28 July 2018 Pages: 14 - 14

15. Abatacept/azathioprine

    Case report 28 July 2018 Pages: 15 - 15

16. Abatacept/methotrexate

    Case report 28 July 2018 Pages: 16 - 16

17. Abiraterone acetate

    Case report 28 July 2018 Pages: 17 - 17

18. Acenocoumarol/linezolid interaction

    Case report 28 July 2018 Pages: 18 - 18

19. Acetylcysteine/paracetamol

    Case report 28 July 2018 Pages: 19 - 19

20. Adalimumab

    Case report 28 July 2018 Pages: 20 - 20

21. Adalimumab

    Case report 28 July 2018 Pages: 21 - 21

22. Adalimumab

    Case report 28 July 2018 Pages: 22 - 22

23. Adalimumab

    Case report 28 July 2018 Pages: 23 - 23

24. Adalimumab

    Case report 28 July 2018 Pages: 24 - 24

25. Adalimumab

    Case report 28 July 2018 Pages: 25 - 25

26. Adalimumab

    Case report 28 July 2018 Pages: 26 - 26

27. Adalimumab

    Case report 28 July 2018 Pages: 27 - 27

28. Adalimumab/azathioprine

    Case report 28 July 2018 Pages: 28 - 28

29. Adalimumab/prednisone

    Case report 28 July 2018 Pages: 29 - 29

30. Adefovir

    Case report 28 July 2018 Pages: 30 - 30

31. Ademetionine/escitalopram

    Case report 28 July 2018 Pages: 31 - 31

32. Afatinib

    Case report 28 July 2018 Pages: 32 - 32

33. Afatinib

    Case report 28 July 2018 Pages: 33 - 33

34. Afatinib/crizotinib/gefitinib

    Case report 28 July 2018 Pages: 34 - 34

35. Albumin human

    Case report 28 July 2018 Pages: 35 - 35

36. Alemtuzumab

    Case report 28 July 2018 Pages: 36 - 36

37. Alemtuzumab

    Case report 28 July 2018 Pages: 37 - 37

38. Alemtuzumab/amphotericin-B/posaconazole

    Case report 28 July 2018 Pages: 38 - 38

39. Alendronic acid/corticosteroid

    Case report 28 July 2018 Pages: 39 - 39

40. Alendronic acid/risedronic acid

    Case report 28 July 2018 Pages: 40 - 40

41. Alendronic acid/zoledronic acid

    Case report 28 July 2018 Pages: 41 - 41

42. Alirocumab/evolocumab

    Case report 28 July 2018 Pages: 42 - 42

43. Allopurinol

    Case report 28 July 2018 Pages: 43 - 43

44. Allopurinol

    Case report 28 July 2018 Pages: 44 - 44

45. Alteplase

    Case report 28 July 2018 Pages: 45 - 45

46. Amantadine overdose

    Case report 28 July 2018 Pages: 46 - 46

47. Ambrisentan/selexipag

    Case report 28 July 2018 Pages: 47 - 47

48. Amikacin

    Case report 28 July 2018 Pages: 48 - 48

49. Amiloride

    Case report 28 July 2018 Pages: 49 - 49

50. Amiodarone

    Case report 28 July 2018 Pages: 50 - 50